For nearly 40 years cellabs has been a pioneer in the development of diagnostic kits for tropical and neglected diseases
ADVANCING POINT OF CARE TESTING
One step HbA1c analyzer
Let’s embark on a new journey together!
Only glucose meter FDA-cleared for use with critically ill patients
A new automated screening technology developed by Japanese researchers enables rapid identification of drug candidates by tracking molecular behaviour within cells, offering significant implications for therapeutic development.
Finnish researchers have developed a high-throughput screening pipeline that enables simultaneous analysis of multiple drug responses in primary tumour samples at single-cell resolution, offering new possibilities for personalised cancer therapy.
Researchers at the University of Bonn have developed an artificial intelligence system that can predict chemical structures of compounds capable of binding to multiple protein targets, potentially streamlining the discovery of more effective therapeutic agents.
Researchers at Linköping University have developed an improved version of the AI protein structure prediction tool AlphaFold, enabling analysis of larger protein complexes and integration of experimental data. The advancement marks a significant step forward in protein research and drug development.
Laboratory equipment manufacturer Asynt has introduced an expanded portfolio of photochemistry reactors, offering researchers enhanced capabilities for both batch and continuous flow applications. This development addresses the growing interest in photochemistry as a ‘reagentless’ activation method in synthetic chemistry.
February | March 2025
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.